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ARTICLE
Nucleus accumbens controls wakefulness by a
subpopulation of neurons expressing dopamine D1
receptors
Yan-Jia Luo1,2,3,4, Ya-Dong Li1, Lu Wang 1,2,3, Su-Rong Yang1,2,3, Xiang-Shan Yuan1, Juan Wang1,
Yoan Cherasse 5, Michael Lazarus 5, Jiang-Fan Chen6, Wei-Min Qu1,2,3 & Zhi-Li Huang1,2,3
Nucleus accumbens (NAc) is involved in behaviors that depend on heightened wakefulness,
but its impact on arousal remains unclear. Here, we demonstrate that NAc dopamine D1
receptor (D1R)-expressing neurons are essential for behavioral arousal. Using in vivo ﬁber
photometry in mice, we ﬁnd arousal-dependent increases in population activity of NAc D1R
neurons. Optogenetic activation of NAc D1R neurons induces immediate transitions from
non-rapid eye movement sleep to wakefulness, and chemogenetic stimulation prolongs
arousal, with decreased food intake. Patch-clamp, tracing, immunohistochemistry, and
electron microscopy reveal that NAc D1R neurons project to the midbrain and lateral
hypothalamus, and might disinhibit midbrain dopamine neurons and lateral hypothalamus
orexin neurons. Photoactivation of terminals in the midbrain and lateral hypothalamus is
sufﬁcient to induce wakefulness. Silencing of NAc D1R neurons suppresses arousal, with
increased nest-building behaviors. Collectively, our data indicate that NAc D1R neuron circuits
are essential for the induction and maintenance of wakefulness.
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The nucleus accumbens (NAc) is the major component ofthe ventral striatum and has long been studied as a keystructure in mediating a variety of neurobiological beha-
viors including motivation, reward, feeding, learning, and cog-
nition1. These higher brain functions operate based on
wakefulness2,3. However, whether the NAc is involved in con-
trolling wakefulness remains to be elucidated.
Converging clinical and animal studies have revealed
sleep–wake alterations in numerous psychiatric disorders asso-
ciated with dysfunctions of the NAc, such as anxiety, depression,
drug abuse, and addiction4–8, implying a close relationship
between the NAc and sleep–wake regulation. Qiu et al.9 report
that nonspeciﬁc lesions of the NAc by ibotenic acid result in an
increase in wakefulness. In contrast, Tellez et al.10 performed
in vivo electrophysiological recordings in the NAc of rats and
found that a large population of NAc neurons decrease their
ﬁring rate during slow-wave sleep. In addition, microinjection of
dopamine (DA) D1 or D2/D3 receptor (R) agonists into the NAc
increases locomotion and wakefulness11. Moreover, very recently,
a study showed that optogenetically activating dopaminergic
ventral tegmental area (VTA) terminals in the NAc promotes
arousal in freely behaving mice12. However, the role of the NAc in
mediating sleep or wakefulness is controversial. Therefore, roles
of NAc in the regulation of sleep–wake cycle and the underlying
neural circuits remain to be elucidated.
The NAc is mostly composed of two subtypes of GABAergic
projection neurons: one expresses DA D1Rs, and the other
expresses D2Rs13. Emerging evidence indicates that D1R and
D2R-expressing neurons play complementary and sometimes
opposing roles in higher brain functions involving reward, sen-
sitization, feeding, and depression-like behaviors14–17. For
example, repeated cocaine exposure potentiates output of D1R
neurons but weakens output of D2R neurons in the NAc18. NAc
D1R neuron activation enhances conditional place preference for
cocaine and morphine, whereas D2R neuron activation prevents
it19,20. In addition, acute cocaine or morphine administration
promotes wakefulness21, showing predominant c-Fos immunor-
eactivity in D1R neurons in the NAc13,22. These ﬁndings suggest
that NAc D1R neurons, but not D2R neurons, play important
roles in functional modulation of arousal-based behaviors.
Recently, Oishi et al.23 ﬁnd that direct stimulation of the NAc
A2AR/D2R-expressing neurons induces remarkable non-rapid eye
movement (NREM) sleep. Therefore, we hypothesize that D1R-
expressing neurons in the NAc may be important for generation
of wakefulness.
In the present study, ﬁber photometry was employed to
investigate the activity of NAc D1R neurons during spontaneous
sleep–wake cycle. Chemogenetic and optogenetic approaches
combined with polysomnographic recordings were used to
investigate the necessity of NAc D1R neurons in arousal. Patch-
clamp recordings and immunoelectron microscopy were per-
formed to assess the functional connectivity between NAc D1R
neurons and neurons in the midbrain and lateral hypothalamus
(LH). We further examined the feeding and nest-building beha-
viors during NAc D1R neuron activation and inhibition. Finally,
bidirectional modulation of D2R neurons was used to identify the
possible local circuit between NAc two subpopulations in
sleep–wake regulation. Our results provide several lines of evi-
dence regarding NAc D1R neuron circuit diagram for arousal
control.
Results
Population activities of NAc D1R neurons increase during
wake. To investigate real-time activity of NAc D1R neurons
across spontaneous sleep–wake cycles of freely moving mice, we
used ﬁber photometry technology24 to examine calcium signals of
NAc D1R neurons. Following stereotaxic infusion of the Cre-
dependent adeno-associated virus (AAV) encoding the ﬂuor-
escent calcium indicator GCaMP6f (AAV-EF1α-DIO-GCaMP6f)
into the right NAc of 3 D1R-Cre mice, we implanted a ﬁber optic
with its tip into the NAc, and electrodes for simultaneously
recording electroencephalogram/electromyogram (EEG/EMG) to
judge sleep–wake states (Fig. 1a, b). To test the cell phenotype
speciﬁcity of the viral vectors, we used immunoﬂuorescence
staining for substance-P (SP, a marker for D1R neurons), and
found that majority of GCaMP6f expressing cells were SP positive
(Fig. 1c). When GCaMP and EEG/EMG signals were recorded in
the home cage of mice, we observed that sleep–wake stages were
consistently associated with changes in D1R neuron population
activity (Fig. 1d, f); i.e., during NREM sleep, NAc D1R neurons
displayed a lower GCaMP signal than during either wakefulness
or rapid eye movement (REM) sleep (Fig. 1d, e). Notably, NAc
D1R cells began to increase neuronal activities before NREM-to-
wake and NREM-to-REM transitions and decrease neuronal
activities before wake-to-NREM transitions (Fig. 1d, f). These
ﬁndings clearly indicate a mechanistic framework for the parti-
cipation of NAc D1R neurons in the regulation of sleep and
wakefulness.
Chemogenetic activation of NAc D1R neurons increases wake.
To examine the effect of NAc D1R neuron activation on elec-
trocortical and behavioral wakefulness, we expressed a Cre-
recombinase-enabled chemogenetic excitatory system under the
control of the human synapsin promoter (AAV-hSyn-DIO-
hM3Dq-mCherry), via AAV injections, in the bilateral NAc of 8
D1R-Cre mice (NAc-hM3Dq mice; Fig. 2a). CNO did not affect
sleep-wake proﬁles of mice transduced with control virus AAV-
hSyn-DIO-mCherry (Supplementary Fig. 2a, b). Whole-cell
current-clamp recordings of NAc D1R neurons expressing
hM3Dq showed depolarization with clozapine N-oxide (CNO)
treatment (27.8 ± 1.2 mV, n= 8 cells), which was sufﬁcient to
elicit action potentials (Fig. 2b). In addition, intense nuclear c-Fos
immunostaining was observed in hM3Dq-expressing (mCherry
+) neurons (Fig. 2c) following systemic CNO administration
in vivo, indicating strong activation of NAc D1R neurons by the
hM3Dq ligand.
Next, we implanted the mice with EEG/EMG electrodes for
sleep–wake monitoring and investigated the effect of NAc D1R
neurons activation in freely moving mice. Either vehicle or CNO
was injected intraperitoneally (i.p.) into NAc-hM3Dq mice at
09:00 (2 h after lights on) when mice usually show a high level of
spontaneous sleep, which is characterized by a typical light phase
hypnogram with long bouts of NREM sleep marked by high EEG
delta power and low EMG activity. CNO signiﬁcantly increased
wakefulness with decreases in NREM and REM sleep during the
2 h following administration, as compared with vehicle
(Fig. 2d–f). For the total amount of time spent in wakefulness,
NREM sleep, and REM sleep during the 2 h post-injection period,
CNO at 3 mg/kg resulted in a 98.4% increase in wakefulness, with
93.5% and 68.7% reductions in NREM and REM sleep,
respectively (Fig. 2g). EEG power spectra during wakefulness
induced by NAc D1R neuron activation were similar to spectra
displayed during spontaneous wakefulness (Fig. 2h). Similarly,
when injected during dark period in which mice show a high level
of arousal, CNO signiﬁcantly increased wakefulness (Supplemen-
tary Fig. 1a–d), further demonstrating that activation of NAc D1R
neurons prolonged arousal even in the dark (active) period.
Moreover, injection of CNO at 3 mg/kg but not l mg/kg and
vehicle signiﬁcantly increased locomotor activity (Supplementary
Fig. 3a–d), suggesting activation of NAc D1R neuron-induced
behavioral arousal.
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To examine whether NAc D1R neuron activation would affect
sleep-related behavior (nest-building), we removed the old nest
from the home cage following administration of vehicle or CNO
3mg/kg at 9:00, and then provided new paper and quantiﬁed
nest-building 3 h after injections (Fig. 2i). We found that hM3Dq
mice administered with CNO built a poorer nest than control
groups did during the light period (Fig. 2j). Moreover, food intake
was signiﬁcantly reduced 2 h after CNO dosing, and this effect
lasted for at least 24 h (Fig. 2k), indicating that activation of NAc
D1R neurons decreases food intake.
Taken together, these results indicate that selective activation
of NAc D1R-expressing neurons generates wakefulness, along
with disrupted nest-building behavior and food intake.
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Fig. 1 Population activities of NAc D1R neurons across sleep–wake states. a Schematic of the ﬁber photometry setup and in vivo recording conﬁguration.
DM dichroic mirror, PMT photomultiplier tube. b Unilateral viral targeting of AAV-EF1α-DIO-GCaMP6f into the NAc and the tip of ﬁber optic above the
NAc. Scale bar: 1 mm. Right: Viral expression of GCaMP6f and the placement of ﬁber-optic probe above the NAc. Scale bar: 200 μm. c The 40× confocal
images from a NAc D1R neurons::GCaMP6f brain section immunostained for substance P (SP) and DAPI displaying the colocalization between GCaMP6f-
positive neurons (green) and SP (red) cells. White arrowheads highlight NAc D1R neurons expressing GCaMP6f. Scale bar: 10 μm. d Representative
ﬂuorescence traces, relative EEG power, and EEG/EMG traces across spontaneous sleep–wake states. ΔF/F represents change in ﬂuorescence from
median of the entire time series. e Fluorescence (mean ± s.e.m.) during wake, NREM sleep, and REM sleep for 3 mice, the ﬂuorescence signal is the highest
during REM sleep, intermediate during wake, and the lowest during NREM sleep (n= 3 mice, 10 sessions per mouse, one-way ANOVA followed by
Turkey’s post hoc test; F2,87= 164.9, P= 2 × 10−30; P (wake–NREM) = 5 × 10−9, (wake–REM) = 3 × 10−6, (NREM–REM) = 5 × 10−9). f Fluorescence
signals aligned to wake state transitions. Upper panel, individual transitions with color coded ﬂuorescence intensity (NREM–wake, n= 141; wake to NREM,
n= 204; NREM to REM, n= 78; REM to wake, n= 73). Lower panel, mean (blue trace) ± s.e.m. (gray shading) showing the average calcium transients
from all the transitions. **P<0.01
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Fig. 2 Chemogenetic activation of NAc D1R neurons increases wake and suppresses nest-building behavior and food intake. a Drawings of superimposed
AAV injection sites in the NAc of D1R-Cre mice (n= 8, indicated with different colors). b Representative voltage traces recorded from an mCherry-
expressing neuron during the application of CNO. CNO produced depolarization and ﬁring in an hM3Dq-expressing neuron (left), and induced signiﬁcant
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injection at 09:00. f Time course changes in wakefulness, NREM sleep, and REM sleep after administration of vehicle or CNO to mice expressing hM3Dq in
NAc D1R neurons (n= 8, repeated-measures ANOVA; F1,14= 11.9 (wake), 11.6 (NREM), 12.4 (REM); P= 0.004 (wake), 0.004 (NREM), 0.003 (REM)). g
Total time spent in each stage for 2 h after vehicle or CNO injection (n= 8, paired t test). h EEG power density of wake during the 2 h after vehicle or CNO
injection (n= 8, paired t test; not statistically signiﬁcant). i Diagram of experiment. j Nesting score was assessed in 4 groups (n= 8 per group, Wilcoxon
matched-pairs signed rank test: mCherry: Z= 0.6, P= 0.5; hM3Dq: Z= 2.3, P= 0.02). k Systemic application of CNO signiﬁcantly reduced food
consumption (n= 6 per group, paired t test). Data represent mean ± s.e.m. *P < 0.05, **P < 0.01
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Optogenetic activation of NAc D1R neurons initiates wake.
Because optogenetics can achieve millisecond timescale control of
neuronal activity, we used optogenetic methods to examine the
capacity of NAc D1R neurons to initiate wakefulness. AAV-hSyn-
DIO-ChR2-mCherry or AAV-hSyn-DIO-mCherry was delivered
to the NAc of D1R-Cre mice (ChR2-mCherry mice or mCherry
mice). In vitro experiments conﬁrmed that ChR2 was driven by
the blue light with high temporal precision (Supplementary
Fig. 4a–g), and optogenetic stimulation evoked inhibitory post-
synaptic responses in ChR2-negative neurons (putative D2R/
A2AR neurons; Supplementary Fig. 4h–k), reﬂecting collateral
innervation between NAc neurons.
We applied laser stimulation through optical ﬁbers implanted
bilaterally above the NAc 3 weeks after virus injection and
quantitatively analyzed EEG/EMG signals recorded simulta-
neously (Fig. 3a). We stimulated the NAc in vivo in ChR2-
mCherry mice with 5 ms pulses of blue light at 20 Hz for 16 s
during NREM sleep, and stimulation trials always began 20 s after
onset of NREM sleep. After photostimulation, most mCherry-
positive neurons were c-Fos-activated in ChR2-mCherry mice
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(Fig. 3b, c), indicating activation of ChR2-expressing D1R
neurons by optogenetic stimulation. In addition, 20 Hz stimula-
tion of the bilateral NAc produced immediate transitions from
NREM sleep to wakefulness in ChR2-mCherry mice (5.7 ± 1.4 s;
Fig. 3d, e, j and Supplementary Movie 1) but not in mCherry mice
(80.2 ± 4.2 s; Fig. 3g, h, j and Supplementary Movie 2). In ChR2-
mCherry mice, optogenetic stimulation induced immediate
cortical activation, which was characterized by a signiﬁcant
decrease in slow-wave activity (a hallmark of sleep pressure)
(Fig. 3d, e). In some cases, the NREM-to-wake transition
occurred during the 16 s optical stimulation and was character-
ized by initial EEG desynchronization without EMG activity
followed by head and/or limb movements with increased EMG
tone (Supplementary Fig. 5c–f). We analyzed the lag responses
and found that in 67.4% of the trials (31 out of 46 trials,
5–12 stimulations per mouse, n= 6 mice), the increased EMG
occurred at least 1 s after cortical EEG power changed following
bilateral optical stimulation at 20 Hz for 16–20 s (Supplementary
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Fig. 5a, b), strongly indicating that NAc D1R neuron activation-
induced arousal was not caused by movement. Moreover,
unilateral photostimulation at 20 Hz was also sufﬁcient to induce
NREM sleep-to-wake transitions, without obvious unilateral
motor effects such as rotation or direction bias (Supplementary
Movie 3). Next, by applying 5 ms pulses of photostimulation at
5–50 Hz for 1–16 s during NREM sleep in the light (inactive)
period, we found that the probability of transition from NREM
sleep to wakefulness increased with frequency and duration of
stimulation after the onset of photostimulation in ChR2-mCherry
mice, but not in mCherry mice (Fig. 3f, i). These data establish a
causal role for NAc D1R neurons in initiating wakefulness.
Long-term optical activation of NAc D1R neurons maintains
wake. To determine whether NAc D1R neurons maintain wake-
fulness, we gave photostimulation for 1 h during the light period
(09:00–10:00). Sustained activation of NAc D1R neurons using a
semi-chronic optical stimulation procedure (5 ms blue light pul-
ses at 20 Hz for 10 s, every 30 s for 1 h) signiﬁcantly increased the
amount of wakefulness in ChR2-mCherry mice compared with
baseline control between 09:00 and 10:00 (27.5 ± 5.0 min at
baseline vs. 44.9 ± 3.1 min after stimulation, n= 5; Fig. 3k, l).
Meanwhile, the amount of time spent in both NREM sleep
(baseline: 29.5 ± 5.0 min; stimulation: 14.2 ± 2.8 min) and REM
sleep (baseline: 3.1 ± 0.4 min; stimulation: 0.9 ± 0.6 min) was
signiﬁcantly reduced (Fig. 3l). These ﬁndings demonstrate that
NAc D1R neurons are potent in maintaining wakefulness.
NAc D1R neurons mainly target midbrain non-DA neurons.
Following AAV-hSyn-DIO-ChR2-mCherry virus injections into
the NAc of D1R-Cre mice (Supplementary Fig. 7a, b), we
observed the projections to the ventral midbrain. NAc D1R
neuron terminals were distributed mainly in the medial sub-
stantia nigra pars compacta (SNc) and VTA and sparsely in the
substantia nigra pars reticulata (SNr, Supplementary Fig. 7h–m).
To understand better the nature of synaptic connections from
NAc D1R neurons to neurons in different midbrain subregions,
we functionally mapped underlying NAc –midbrain connections
using electrophysiological recordings in coronal brain slices
containing the SNc and VTA of ChR2-mCherry mice (Fig. 4a–o).
We classiﬁed neurons in the midbrain into two classes based on
their electrophysiological properties as described in previous
studies25,26. We deﬁned type 1 neurons, presumably dopami-
nergic neurons, when they met the following three criteria: (1)
resting membrane potential (RMP) more depolarized than −70
mV and ﬁred spontaneous action potentials at frequencies lower
than 10 Hz or were quiescent, (2) a pronounced
hyperpolarization-activated inward current termed Ih (Fig. 4c,
left), and (3) broad action potentials (spike duration >1.3 ms)
with a pronounced after-hyperpolarization (Fig. 4c, right).
Neurons that did not satisfy these criteria were identiﬁed as non-
type 1 neurons. The mean action potential duration for type 1
neurons was signiﬁcantly longer than that of non-type 1 neurons
(2.6 ± 0.1 ms vs. 1.2 ± 0.1 ms; Fig. 4e, left), and the RMP of type 1
neurons was more positive (−53.7 ± 0.7 ms vs. −66.2 ± 2.1 mV;
Fig. 4e, right). NAc D1R neurons are believed to release the
neurotransmitter GABA upon activation and thus may inhibit
postsynaptic targets. Therefore, recorded neurons in the midbrain
were considered to have functional connections with NAc D1R
neurons if decreased ﬁring rates and evoked inhibitory post-
synaptic currents (IPSCs) (Fig. 4g, h, j, k) were observed when
photostimulations activated axonal terminals of NAc D1R neu-
rons. We found that NAc D1R neurons disproportionately tar-
geted non-type 1 neurons in the midbrain (Fig. 4f). By adding
biocytin to the recording microelectrode solution to allow sub-
sequent immunohistochemical staining for tyrosine hydroxylase
(TH), a marker for DA neurons, we conﬁrmed that NAc D1R
neurons mainly targeted TH-negative but not TH-positive neu-
rons in the midbrain (Fig. 4i–l, n, o). These ﬁndings indicate that
type 1 neurons are TH-positive DA neurons. Notably, since some
non-type 1 neurons (7 out of 28 neurons, 25%) were also Ih
positive (Fig. 4d), it is not reasonable to distinguish DA neurons
and non-DA neurons based on Ih current alone.
Then, as both the SNc and VTA contain DA and non-DA
neurons, it is likely that non-DA neurons are primarily
GABAergic25,27. We detected messenger RNA (mRNA) in three
connected neurons using single-cell reverse-transcription PCR
(RT-PCR) to conﬁrm vesicular GABA transporter (Vgat)
expression (2 out of 3; Fig. 4m). Using immunoelectron
microscopy, we found mCherry-immunoreactive terminals estab-
lishing symmetric synapses with TH-negative dendrites in the
midbrain (n= 44 synapes; Fig. 4p), while no synapses were
observed between mCherry-immunoreactive terminals and TH-
positive dendrites (data not shown). We also found that TH-
positive dendrites formed symmetric and asymmetric synapses
with mCherry-negative structures (n= 179 vs. 43; Fig. 4q, r).
These ﬁndings indicate that NAc D1R neurons mostly target
GABAergic neurons in the midbrain. Since DA neurons in the
midbrain are usually inhibited by neighboring GABAergic
neurons28, we postulated that direct photostimulation of NAc
D1R neurons connected to the midbrain pathway could drive
disinhibition of DA neurons.
NAc D1R neurons sparsely target NAc-projecting VTA DA
neurons. Neurons in the VTA and SNc send projections to
ventral and dorsal parts of the striatum, respectively27, and we
next determined whether there are differences between NAc –
SNc and NAc –VTA pathways. By injecting the retrograde tracer
CTB-488 into the dorsomedial striatum (DMS) or NAc (Fig. 5a, f)
after AAV-ChR2 injection into the NAc, we identiﬁed DMS
Fig. 4 NAc D1R neurons preferentially send inhibitory inputs to TH-negative neurons in the midbrain. a Schematic of experiment. AAV-ChR2 was injected
into the NAc of D1R-Cre mice, and the response was recorded in the midbrain (VTA/SNc). b Representative image of terminals in the midbrain from NAc
D1R neurons. Scale bars: 500 μm. ac anterior commissure, ml medial lemniscus. c Electrophysiological properties of Type 1 neurons in the midbrain. d Non-
type 1 neurons consist of both Ih-positive and Ih-negative neurons. e Comparison of action potential duration (left) and resting membrane potential (RMP,
right) from type 1 and non-type 1 neurons (n= 26 type 1 neurons, n= 28 non-type 1 neurons, from 17 mice, unpaired t test; action potential duration: t52=
8.7, P= 1 × 10−11; RMP: t52= 5.6, P= 9 × 10−7). f Proportion of connected and unconnected neurons that were identiﬁed as type 1 (n= 26 type 1 neurons,
n= 28 non-type 1 neurons, from 17 mice, Chi-square test; χ2= 30.1, P= 2 × 10−8). g–i Representative images of a non-connected biocytin-ﬁlled neuron
that was TH-positive. Scale bar: 20 μm. TH tyrosine hydroxylase. j–l Typical example of a connected biocytin-labeled neuron that was TH negative and
responsive to light stimulation. Scale bar: 20 μm. m Representative results from a single-cell RT-PCR reaction conﬁrming the Vgat phenotype of a
connected cell. n Latency (left axis) and amplitude (right axis) of light-evoked IPSCs in midbrain non-TH neurons. o Summary of TH immunocytochemistry
for connected and unconnected neurons (n= 18 TH (+) neurons, n= 21 TH (–) neurons, from 17 mice, Chi-square test; χ2= 24.9, P= 4 × 10−7). p
Electron microscopy image of an mCherry-immunoreactive terminal (mt) that formed a symmetric synapse (arrow) with an unlabeled dendrite (ud). Scale
bar: 0.5 μm. q A representative image of a TH-positive dendrite (Td) that established a symmetric synapse (arrow) with unlabeled terminals (ut). Scale
bar: 0.5 μm. r A TH-positive dendrite (Td) that established an asymmetric synapse (arrowhead) with unlabeled terminals (ut). Scale bar: 0.5 μm. **P < 0.01
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retrogradely labeled cell bodies in the SNc (Fig. 5b) and NAc
retrogradely labeled cell bodies in the VTA that overlapped with
ﬁbers containing ChR2 (Fig. 5g). In the SNc, we recorded 12
CTB-488 retrogradely labeled neurons, and none of the labeled
neurons was responsive to photostimulation (Fig. 5c, d). These
neurons displayed typical electrophysiological properties of DA
neurons, and all of them stained positive for TH (Fig. 5e), indi-
cating that the SNc DA neurons were not innervated by NAc D1R
neurons. We then recorded 19 retrogradely labeled VTA neurons,
and all 19 neurons were TH positive (Fig. 5j). Interestingly, only
two of these neurons responded to light stimulation with evoked
IPSCs (Fig. 5h, i). Taken together, our data show that NAc D1R
neurons do not innervate DA neurons in the SNc, which project
to the DMS, and sparsely to DA neurons in the VTA.
NAc D1R neurons promote wake via midbrain and LH con-
nections. To elucidate the neuronal circuits mediating the wake-
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promoting effect of NAc D1R neurons, ChR2 was expressed in the
NAc with optic ﬁbers targeting terminals in the ventral medial
midbrain (Fig. 6a, b) or LH (Fig. 6g, h), based on the NAc D1R
neurons projections14,29 (Supplementary Fig. 7f–m). Brief blue
light stimulation at 20 Hz induced an immediate transition from
NREM sleep to wakefulness in the midbrain (latency: 5.2 ± 0.9 s;
Fig. 6c, Supplementary Movie 4) or LH (latency: 6.0 ± 1.1 s;
Fig. 6i, Supplementary Movie 6). Following yellow light stimu-
lation as a control, no change was observed (Fig. 6d, j and Sup-
plementary Movie 5). Short latencies for sleep-to-wake transition
were observed during blue light pulses at the frequencies higher
than 20 Hz in the midbrain (Fig. 6e) or LH (Fig. 6k). To identify
the effects of long-term stimulation on the wake-promoting effect
of NAc D1R neuron terminals, we applied photostimulation for
1 h during 09:00 to 10:00. Optogenetic stimulation of NAc D1R
neuron terminals in the midbrain (Fig. 6f) or LH (Fig. 6l)
increased waking time by 86.4% and 79.4%, respectively, and both
with a decrease in NREM sleep and REM sleep compared to
controls (Fig. 6f, l). Taken together, these results show that the
NAc-midbrain and NAc-LH circuits mediated arousal controlling
effect of NAc D1R neurons (Supplementary Fig. 8a, b).
To test whether NAc D1R neurons directly inhibit wake-
promoting LH GABA neurons30,31, we crossed D1R-Cre and
GAD67-GFP mice to generate a new mouse D1R-Cre::GAD67-
GFP. AAV-hSyn-DIO-ChR2-mCherry was injected into the NAc,
and in vitro whole-cell recording of LH GABA neurons was used
to simultaneously monitor light-evoked IPSCs derived from NAc
D1R neurons afferents (Supplementary Fig. 6a). We found that
both green ﬂuorescent protein (GFP)-positive and -negative
neurons received inhibitory inputs from NAc D1R neurons, with
no signiﬁcant difference in connection probability (67% vs. 47%;
Supplementary Fig. 6b, d–g). Meanwhile, light-evoked IPSCs
latency was less than 5 ms (Supplementary Fig. 6c), indicating the
direct connection. Because GAD67 is a marker for GABA, our
results suggested that NAc D1R neurons would target both GABA
neurons expressing GAD67 and non-GAD67 neurons including
GAD65 GABAergic neurons and non-GABAergic neurons. In
hM3Dq study, we found robust c-Fos expression in LH orexin-
positive neurons after NAc D1R neuron activation (Supplemen-
tary Fig. 6h, i). Taken together, these ﬁndings suggest prominent
functional synaptic connectivity between NAc D1R neurons and
LH neurons, and NAc D1R – LH circuit involving arousal control
may be partially through activating LH wake-promoting orexin
neurons.
NAc D1R neurons are necessary for wakefulness. To determine
whether NAc D1R neurons are necessary for sustaining wake-
fulness, we used an inhibitory modiﬁed muscarinic G protein-
coupled receptor (AAV-hSyn-DIO-hM4Di-mCherry) to selec-
tively silence NAc D1R neurons (Fig. 7a). In vitro study showed
that CNO (5 μM) substantially decreased the number of evoked
action potentials (Fig. 7b). Following i.p. CNO injection at 09:00,
total wakefulness during 3 h after CNO administration was sig-
niﬁcantly decreased, concomitant with an increase in NREM
sleep, as compared with vehicle controls (n= 9, P < 0.05, Fig. 7c,
d). In addition, fast Fourier transform analysis of NREM sleep
showed an increase in slow delta power in the frequency range of
0–2 Hz (Fig. 7e). Similarly, CNO administration at 21:00 also
resulted in a 70.7% increase in NREM sleep during 3 h after
injection, which was accompanied by a decrease in wakefulness
(Fig. 7f). Moreover, inhibition of D1R neurons did not change
EEG power of NREM and REM sleep (Fig. 7g). Sleep typically
occurs in the home environment or nest12. To test this, we
assessed nest-building behavior. CNO-treated hM4Di mice
increased nest building during the test period compared with
three control groups (Fig. 7h, i). Finally, inhibition of NAc D1R
neurons produced no noticeable changes in food intake following
both 2 h and 24 h periods (Fig. 7j). Taken together, these results
indicate that NAc D1R neurons are essential for the maintenance
of physiological arousal.
NAc D2R neurons are important to promote NREM sleep. To
test whether arousal-promoting effect of D1R neurons is partly
due to the inhibition of NAc D2R neurons, we injected hSyn-
DIO-hM4Di-mCherry in the bilateral NAc of D2R-Cre mice
(Fig. 8a, b) to inhibit D2R neuron activities. Current-clamp
recordings from an hM4Di-expressing D2R neuron showed
decreased action potentials in response to 250 pA current injec-
tion during bath application of 5 μM CNO (Fig. 8c). Adminis-
tration of CNO at 21:00 signiﬁcantly increased wakefulness by
37.9%, with a decrease in NREM sleep and REM sleep by 97.2%
and one-fold during the 2 h post-injection period, respectively,
relative to vehicle (Fig. 8d–f). Finally, we examined the sleep-
promoting effect after activation of D2R neurons by CNO in D2R-
Cre mice transduced with hM3Dq in the NAc (Fig. 8g, h). In vitro
patch-clamp recordings of NAc neurons expressing hM3Dq
showed the increased ﬁring response to 180 pA current injection
during bath application of 5 μM CNO (Fig. 8i). We found that
systemic administration of CNO increased NREM sleep by 2.6-
fold and decreased wakefulness by 51.5% during the 2 h post-
injection period as compared with vehicle (Fig. 8j–l). These
results demonstrate that inhibition of NAc D2R neurons mimics
the effect of activation of accumbal D1R neurons, and conﬁrm
that two subpopulations of D1R and D2R neurons in the NAc
play opposite roles in sleep–wake control.
Discussion
The NAc has long been studied as a key brain region mediating a
variety of behaviors1,32–34 such as locomotion, emotion, cognitive
behavior, learning, feeding, action selection, sexual motivation, as
well as reward and reinforcement. These behaviors ensure sur-
vival and reproduction in nature, which depend on heightened
Fig. 5 NAc D1R neurons sparsely target NAc-projecting VTA DA neurons. a Schematic of the experimental protocol. Cre-dependent ChR2 was injected into
the NAc of D1R-Cre mice, while retrograde tracer CTB-488 was injected into the DMS. Infected terminals (red) were optogenetically activated, and
recordings were obtained from retrogradely labeled SNc projection neurons (green). DMS dorsomedial striatum. b Representative images of ChR2-
mCherry and CTB-488 at the injection sites and their anterogradely and retrogradely labelings in the midbrain slice. Left, scale bars: 500 μm. Right, scale
bar: 200 μm. c Whole-cell recordings from a DMS projecting SNc neuron did not respond to blue light (5 ms pulses at 20 Hz). d No DMS projecting SNc
neurons showed connections with NAc D1R neurons (n= 12 cells from 3 mice). e Representative confocal images showing a retrogradely labeled SNc
neuron that was TH-positive (magenta). Scale bar: 20 μm. f Schematic of the experiment. Cre-dependent ChR2 and retrograde tracer CTB-488 were
injected into the NAc of D1R-Cre mice, and recordings were obtained from retrogradely labeled VTA projection neurons (green). g Images showing ChR2-
mCherry and CTB-488 injection in the NAc and anterogradely and retrogradely labeling in the midbrain. Left, scale bars: 200 μm. Right, scale bar: 200 μm.
h Representative traces of optogenetically generated picrotoxin (PTX, 100 μM)-sensitive postsynaptic currents recorded from a retrogradely labeled VTA
neuron. i Ten percent of NAc-projecting VTA neurons showed connections with NAc D1R neurons (n= 19 cells from 3 mice). j Representative confocal
images of VTA slices showing a retrogradely labeled neuron (arrowhead) was TH positive and another patched cell not retrogradely labeled (arrow) was
TH negative. Scale bar: 20 μm
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arousal. By recording and manipulating the activity of a sub-
population in the NAc with ﬁber photometry, chemogenetics,
optogenetics, behavioral tests, and polysomnographic methods,
we demonstrate a prominent contribution of NAc D1R neurons
to the control of wakefulness and the neuron circuits in arousal
control.
Compared with traditional methods lacking cellular speciﬁcity,
the recently developed optogenetic and chemogenetic approaches
enable us to manipulate the activity of speciﬁc neurons, thus
providing powerful tools to examine the roles of different NAc
neuron subpopulations in sleep–wake regulation. We here show
that activation of NAc D1R-expressing neurons induces beha-
vioral arousal, while activation of D2R-expressing neurons
strongly promotes sleep. Opposite roles of different NAc cell
types in regulation of sleep and wakefulness may depend on their
projection patterns, in which only D1R neurons directly project to
the midbrain and LH17,35.
Within the midbrain, there are complex neural circuits invol-
ving dopaminergic, GABAergic neurons, and glutamatergic
neurons. Anatomic studies have suggested that the NAc projects
to all, and provides proportionally more input to DA compared
with non-DA neurons36; our data clearly showed predominant
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Fig. 6 NAc D1R neurons control arousal through midbrain and LH pathways. a, g Schematic diagram showing the location of the optic ﬁber in the midbrain
(a) or LH (g), and the implanted somnographic electrodes of a D1R-Cre mouse injected with AAV-ChR2-mCherry in the NAc. b, h Sections stained for
mCherry showing ChR2-mCherry-positive terminals in the midbrain (b) or LH (h), and the cannula trace showing the optic ﬁbers targeting the nuclei. Scale
bars: 200 μm; f fornix. c, i Representative EEG and EMG traces and the corresponding heat map of EEG power spectrum showing that photostimulation in
the midbrain (c) or LH (i) applied during NREM sleep induced a rapid transition to wakefulness. Dashed lines indicate onset of light stimulation. d, j
Representative EEG and EMG recordings and the corresponding heat map of EEG power spectrum showing that yellow light stimulation in the midbrain (d)
or LH (j) failed to affect the sleep–wake pattern. Scale bars: 8 s. e Mean latencies of wake transitions during NREM sleep after acute photostimulation at
different frequencies (n= 5, paired t test; Base, t4= 0.4, P= 0.7; 5 Hz, t4= 2.4, P= 0.08; 20 Hz, t4= 28.5, P= 9 × 10−6; 50 Hz, t4= 81.8, P= 1.3 × 10−7).
Data analysis was based on an average of 8–12 stimulations per frequency and per mouse. f Total amounts of each stage in the control and 20 Hz
photostimulation in the midbrain during 09:00–10:00 (n= 5, paired t test; t4= 9.5, P= 7 × 10−4 (wake); t4= 9.4, P= 7 × 10−4 (NREM); t4= 3.8, P= 0.02
(REM)). k Mean latencies of wake transitions during NREM sleep after photostimulation at different frequencies (n= 5, paired t test). Data analysis was
based on an average of 8–12 stimulations per frequency and per mouse. l Total amounts of each stage in the control and 20 Hz photostimulation in the LH
during 09:00–10:00 (n= 6, paired t test). Data represent mean ± s.e.m. *P < 0.05, **P < 0.01
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functional connections between NAc D1R neurons and non-
dopaminergic neurons, which was consistent with previous
optogenetic circuit mapping25,37. Targeting of non-DA neurons
in the midbrain by NAc-D1R neurons was further conﬁrmed by
our ultrastructural observations of preferential synapses on non-
DA neurons with immunoelectron microscopy. Collectively,
inhibitory input from NAc D1R neurons to the midbrain disin-
hibits dopamine neurons and promotes wakefulness.
Although dopaminergic cells in the midbrain do not change
average ﬁring rates during the sleep–wake cycle38,39, their
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bursting activity is associated with DA release in the NAc and
dorsal striatum, respectively40. Recently, a study showed that
dopaminergic neurons in the VTA are essential for initiation and
maintenance of wakefulness, which is mostly mediated by NAc
projections40. The NAc and VTA are reciprocally connected,
forming a NAc/GABA-midbrain/GABA-VTA/DA-NAc/GABA
loop that controls wakefulness (Supplementary Fig. 8a, b). Our
data support a model wherein activating an inhibitory projection
from the NAc to the midbrain promotes arousal through inhi-
bition of GABA neurons, which causes disinhibition of DA
neurons to increase DA release in the NAc. This might be a
positive feedback process, because the released DA acts on D1R
and D2R to excite D1R neurons and inhibit D2R neurons. How-
ever, the endogenous somnogen adenosine increases with pro-
longed wakefulness and excites A2AR to initiate sleep, which
presumably prevents overexcitation2,3,41.
The LH is a richly heterogeneous structure, containing a
number of genetically distinct cell populations, including
GABAergic, glutamatergic, and neuropeptide-producing neurons,
which are known to have diverse roles in regulating food intake,
and sleep–wakefulness42,43. Thus, it is critical to identify which
LH neurons receive inhibition from NAc D1R neurons. We found
that NAc D1R neurons innervated both GAD67-positive and
GAD67-negative neurons in the LH, showing no distinct pre-
ference, and NAc D1R – LH circuit involving arousal control may
be partially through activating LH wake-promoting orexin neu-
rons. Nevertheless, other circuits may also be involved. Firstly,
several studies indicated that NAc projection neurons did not
directly innervate melanin-concentrating hormone (MCH)- or
orexin-containing neurons14,44. Besides, scientists suggested NAc
neurons may indirectly send signals to MCH neurons via gluta-
matergic neurons in the anterior LH44. Thus, stimulation of
inhibitory NAc D1R to LH pathway may inhibit sleep-promoting
MCH neurons and induce wakefulness. Furthermore, LH GABA
neurons can fall into separate and distinct populations which
project to different brain areas involved in sleep–wake regula-
tion30,31. Finally, these neurons also contain interneurons, which
inhibit other neurons in the LH by a local network45.
Recently, Liu et al.46 identiﬁed a GABAergic subpopulation of
neurons (lhx6+) in the ventral zona incerta (ZI), which is adja-
cent to the LH, that promotes sleep. They also conducted a ret-
rograde tracing study and conﬁrmed a monosynaptic projection
from NAc to ZI lhx6+ neurons. We examined IPSCs in ZI
neurons following optogenetic stimulation of NAc D1R neuron
terminals in brain slices. Indeed, we observed sparse ChR2-
positive ﬁbers around lhx6+ neurons in the ZI (Supplementary
Fig. 9a, b), but we did not detect functional connection (n= 7
cells from 2 mice), suggesting that NAc D1R – ZI pathway might
not be crucial for arousal regulation of NAc D1R neurons. Taken
together, NAc D1R – LH circuit is independent and crucial in the
modulation of arousal, but detailed functional circuit mapping
deserves further study.
It has been reported that NAc A2AR –VP pathway is essential
for mediating sleep23, and although both NAc D1R- and D2R-
expressing neurons innervate the VP (Supplementary Fig. 7c–e),
quantitative analysis revealed less than 3% colocalization of D1R-
and D2R-expressing ﬁbers in the VP, strongly indicating separate
D1R- and D2R-neurons projections to the VP47. Whether and
how the NAc D1R –VP pathway is mediating wakefulness is
unknown, and since the VP serves as an output nucleus of the
basal ganglia that sends inhibitory projections to different brain
regions47,48, it raises the possibility that the NAc D1R –VP and
NAc D2R –VP pathways control sleep–wake states by targeting
different subsets of VP neurons. Further studies are needed to
uncover the role of the NAc D1R –VP pathway in sleep–wake
regulation.
Patients or animals with acute morphine administration dis-
play insomnia7,21, and an immunohistological study indicates
that acute morphine injection predominately activates NAc D1R
neurons22, which is consistent with our ﬁndings that activation of
D1R neurons induces wakefulness. Therefore, our data support a
role of NAc D1R neurons in pathological sleep disorders.
In conclusion, we found that NAc D1R-expressing neurons are
essential in controlling wakefulness and are involved in physio-
logical arousal via the LH and midbrain circuits, suggesting that
the NAc should be considered as a potential target area for
therapy in neuropsychiatric disorders with sleep–wake
alterations.
Methods
Animals. D1R-Cre ((B6.FVB(Cg)-Tg(Drd1a-Cre) EY266Gsat/Mmucd, GENSAT)
mice49 were kindly provided by Jiang-Fan Chen. D2R-Cre (B6.FVB(Cg)-Tg(Drd2-
cre)ER44Gsat/Mmucd, GENSAT) mice were generously provided by Dong-Min
Yin. GAD67-GFP knock-in mice50 were obtained from Yuchio Yanagawa. We
crossed D1R-Cre and GAD67-GFP mice to generate a new mouse D1R-Cre::
GAD67-GFP. Transgenic mice had been backcrossed in the C57BL/6 line for a
minimum of four generations. Male mice at 10–16 weeks of age were used for
behavioral experiments, whereas mice of either sex at 4–8 weeks of age were used
for in vitro patch-clamp experiments. Mice had access to food and water ad libitum
and were maintained at constant temperature (22–24 °C), humidity (40–60%), and
12 h light/dark cycle (100 Lux, light on at 07:00)51. All experimental procedures
involving animals were approved by the Animal Experiment and Use Committee at
the Shanghai Medical School of Fudan University.
AAV generation. The AAVs of serotype rh10 for AAV-hSyn-DIO-hM3Dq-
mCherry, AAV-hSyn-DIO-hM4Di-mCherry, AAV-hSyn-DIO-ChR2-mCherry,
and AAV-hSyn-DIO-mCherry were generated by tripartite transfection (AAV2/10
expression plasmid, adenovirus helper plasmid, and pAAV plasmid) into 293A
cells. After 3 days, the 293A cells were resuspended in artiﬁcial cerebrospinal ﬂuid
(aCSF), freeze–thawed four times, and treated with benzonase nuclease (Millipore)
to degrade all forms of DNA and RNA. Subsequently, the cell debris was removed
by centrifugation and the virus titer in the supernatant was determined using an
AAVpro Titration Kit for Real-Time PCR (Takara). The ﬁnal viral concentrations
of the transgenes were 1–2 × 1012 genome copies/mL. AAV vector carrying the
EF1α-DIO-GCaMP6f construct was packaged into AAV2/9 serotype with titers
1–2 × 1012 genome copies/mL (Shanghi Taiting Biological Co., Ltd. Shanghai,
China).
Fig. 7 Chemogenetic inhibition of NAc D1R neurons increases NREM sleep and promotes nest-building. a Drawings of superimposed AAV injection sites in
the NAc of D1R-Cre mice (n= 9, indicated with different colors). b Representative traces showing that CNO decreased the number of evoked action
potentials in an hM4Di-expressing neuron. c Time course of wakefulness, NREM sleep, and REM sleep after administration of vehicle or CNO at 09:00 (n
= 9, repeated-measures ANOVA; F1,16= 26.7 (wake), 24.9 (NREM), 0.3 (REM); P= 8 × 10−5 (wake), 1 × 10−4 (NREM), 0.6 (REM)). d Total amounts of
each stage for 3 h following treatments during the light period (n= 9, paired t test; t8= 7.2, P= 9 × 10−5 (wake); t8= 6.2, P= 3 × 10−4 (NREM); t8= 0.5,
P= 0.6 (REM)). e EEG power density of NREM and REM sleep after CNO and vehicle injections. Red lines represent P < 0.05 (n= 9, paired t test). f Total
amounts of each stage for 3 h following treatments during the dark period (n= 9, paired t test; t8= 2.9, P= 0.02 (wake); t8= 2.9, P= 0.02 (NREM); t8=
1.9, P= 0.09 (REM)). g EEG power density of NREM and REM sleep after CNO and vehicle injections (n= 9, P > 0.05, paired t test). h Representative
pictures of hM4Di mouse cages following vehicle and CNO administrations at the end of the 3 h test. i Nesting score during the 3 h test (1, poor; 5, good).
Wilcoxon matched-pairs signed rank test, mCherry: n= 8, Z= 0.4, P= 0.7; hM4Di: n= 8, Z= 2.0, P= 0.047. j Inhibition of NAc D1R neurons did not
affect food intake (n= 8 for hM4Di group and n= 6 for control group, paired t test; 2 h, mCherry: P= 0.8, hM4Di: P= 0.2; 24 h, mCherry: P= 0.5, hM4Di:
P= 0.7). Data represent mean ± s.e.m. *P < 0.05, **P < 0.01, NS not signiﬁcant
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Stereotaxic surgery. All mice used were anesthetized with pentobarbital sodium
(50 mg/kg, i.p.) for surgical procedures and placed into a stereotactic frame (RWD,
Shenzhen, China). A burr hole was made, and a ﬁne glass pipette (15–20 µm tip)
containing recombinant AAV-DREADD, AAV-ChR2, or AAV-mCherry virus was
inserted bilaterally into the NAc (anteroposterior (AP)=+ 1.4 mm, mediolateral
(ML)= ± 1.0 mm, dorsoventral (DV)=−3.8 mm). A total of 70–100 nL virus was
delivered to each site over a 10 min period via nitrogen gas pulses of 20–40 psi
using an air compression system, and the needle was left in place for at least 5 min
to permit diffusion as previously described52. Mice that received bilateral injections
were used for all experiments and received additional surgical implants after viral
injection as described below. Only data from mice in which the infection was
conﬁrmed were accepted.
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At 14 days after AAV injection, mice were implanted with EEG and EMG
electrodes for polysomnographic recordings. EEG and EMG signals were recorded
from stainless steel screws inserted on the skull and 2 ﬂexible silver wires inserted
in the neck muscle, respectively. For in vivo optogenetic experiments, additional
stainless steel guide cannulas (8 mm length, RWD, Shenzhen, China) were
positioned bilaterally above the NAc, the LH (AP− 1.5 mm, ML ± 1.0 mm, DV−
4.0 mm), or the midbrain (substantia nigra pars compacta/ventral tegmental area
(SNc/VTA); AP− 3.0 mm, ML ± 1.0 mm, DV− 3.8 mm) before implanting EEG/
EMG electrodes. Cannulas and EEG/EMG electrodes were afﬁxed to the skull with
dental cement. The scalp wound was sutured, and mice were allowed to recover in
a warm plate until it resumed normal activity.
Neuronal tracing. D1R-Cre mice were injected with Alexa Fluor 488-conjugated
cholera-toxin subunit (CTB-488, 0.1%, Life Technologies, USA) either into the
DMS (300 nL, AP+ 0.7 mm, ML −1.6 mm, DV −2.4 mm) or the NAc (200 nL,
AP+ 1.4 mm, ML− 1.0 mm, DV−3.8 mm) 2–3 weeks after AAV-ChR2 injection.
Then, 7 days later, brains were processed for ﬂuorescence imaging or prepared for
in vitro electrophysiological studies.
Polygraphic recordings and analysis. After 2–3 weeks for postoperative recovery
and transgene expression, animals were housed individually in recording chambers
and connected to the EEG/EMG headstages. The recording cable was attached to a
slip-ring unit so that the movement of mice would not be restricted. Mice were
habituated to recording cables for 3–4 days before starting recording.
EEG/EMG signal was recorded under baseline (free moving) and different
treatment conditions (chemogenetic or optogenetic stimulations) over several days.
For DREADD experiments, all mice received vehicle or CNO (3 mg/kg, C2041,
LKT) treatment on 2 consecutive days at 09:00 (inactive period) or 21:00 (active
period), separated by a 3-day wash-out period. After recording, mice were killed 2 h
after vehicle or CNO treatment and then used for immunohistochemical staining.
EEG/EMG signal was ampliﬁed, bandpass ﬁltered (EEG, 5–30 Hz; EMG,
40–200 Hz), digitized at 128 Hz, and recorded with Vital Recorder software (Kissei
Comtec). Sleep state was scored using sleep analysis software (SleepSign, Kissei
Comtec). All scoring was automatic based on EEG and EMG waveforms in 10 s
epochs for chemogenetic studies, while the sleep–wake data were divided into 4 s
epochs in optogenetic and ﬁber photometry studies. We deﬁned wakefulness as
desynchronized EEG and high levels of EMG activity, NREM sleep as
synchronized, high-amplitude, low-frequency (0.5–4 Hz) EEG signals in the
absence of motor activity, and REM sleep as having pronounced theta like (4–9 Hz)
EEG activity and muscle atonia. Vigilance states assigned by SleepSign (Kissei
Comtec, Nagano, Japan) were examined visually and corrected manually if
necessary. Latency to NREM sleep was deﬁned as the time from the end of the
injection to the onset of the ﬁrst NREM sleep episode which lasts more than 20 s.
Optogenetic stimulation during polygraphic recordings. Optical ﬁber cables (1
m long, 200 μm diameter; ThorLabs) were placed inside the implanted cannulas
1 day before stimulation. A rotating optical joint (FRJ_FC-FC, Doric Lenses,
Canada) was used to relieve torque and was attached to the external end of the
optical ﬁber (FC connection). The joint was connected via a ﬁber to a 473 nm blue
laser diode (Newton Inc., Hangzhou, China). Light pulse trains were generated via
a stimulator (SEN-7103, Nihon Kohden, Japan) and output through an isolator (ss-
102J, Nihon Kohden). For acute photostimulation, each stimulation epoch was
applied 16 s after identifying a stable NREM or REM sleep event by real-time
online EEG/EMG analysis. Light pulse trains (5 ms pulses of various frequencies
and durations) were programmed and conducted during the inactive period. For
chronic photostimulation procedure, programmed light pulse trains (5 ms pulses at
20 Hz for 10 s and at 30 s intervals for 1 h) were used. Light stimulation was done
from 09:00 to 10:00. EEG/EMG recorded during the same period on the previous
day served as baseline control. The sleep–wake cycle parameters (amount, bouts,
and mean duration of wakefulness, REM sleep, and NREM sleep, as well as
sleep–wake transitions) were quantiﬁed by ofﬂine scoring of the entire hour for
each animal. Mice that received chronic photostimulation were killed 30 min after
the ﬁnal stimulation for c-Fos staining. Power intensities of blue or yellow light at
the tip of the optical ﬁber were measured by a power meter (PM10, Coherent) and
calibrated to emit 20–30 mW/mm2.
EEG power spectral analysis. Signals were digitally ﬁltered and spectrally ana-
lyzed by fast Fourier transformation using SleepSign software. EEG power spectra
were computed for 8–12 photostimulated events (16 s per event) per mouse, with
16 s before photostimulation as baseline. Mean spectral density of all stimulated
events per animal was sorted into successive 0.25 Hz frequency bands between 0
and 25 Hz. Then, each frequency band was normalized to the sum of the power
over the entire range (0–25 Hz).
Fiber photometry. Following AAV-EF1α-DIO-GCaMP6f virus injection, an
optical ﬁber (125 µm O.D., 0.37 numerical aperture (NA); Newdoon, Shanghai)
was placed in a ceramic ferrule and inserted towards the NAc. Fiber photometry53
uses the same ﬁber to both excite and record from GCaMP in real time. To record
ﬂuorescence signals, laser beam was passed through a 488 nm laser (OBIS 488LS;
Coherent), reﬂected off a dichroic mirror (MD498; Thorlabs), focused by objective
lens (Olympus), and coupled through a ﬁber collimation package (F240FC-A,
Thorlabs) into a patch cable connected to the ferrule of the upright optic ﬁber
implanted in the mouse via a ceramic sleeve (125 µm O.D.; Newdoon, Shanghai).
GCaMP6 ﬂuorescence was bandpass ﬁltered (MF525–39, Thorlabs) and collected
by a photomultiplier tube (R3896, Hamamatsu). An ampliﬁer (C7319, Hama-
matsu) was used to convert the photomultiplier tube current output to voltage
signals, which was further ﬁltered through a low-pass ﬁlter (40 Hz cut-off;
Brownlee 440). The photometry voltage traces were downsampled using inter-
polation to match the EEG/EMG sampling rate of 512 Hz by using a Power1401
digitizer and Spike2 software (CED, Cambridge, UK). Analysis of the resulting
signal was performed with custom written MATLAB software.
Fiber photometry data analysis. Photometry data were exported to MATLAB
Mat ﬁles from Spike2 for further analysis. We derived the value of the photometry
signal (ΔF/F) by calculating (F – F0) / F0, where F0 is the baseline ﬂuorescence
signal. For the sleep–wake analysis, we recorded data for 4–6 h per mouse, and
calculated the averaged ΔF / F during all times of vigilance states. For analyzing the
state transition, we determined each state transition and aligned ΔF/F in a ±50 s
window around that point was calculated.
Nest-building behavior. We injected hM3Dq and hM4Di mice intraperitoneally
with either vehicle or 3 mg/kg CNO during the light (09:00) and dark period
(19:00), respectively, and they were placed in the new home cage with 2 × 6 pieces
(50 × 70 mm) of paper towel (Qingfeng, China). We tested nest-building 3 h later.
Each animal was evaluated following both vehicle and CNO injection, with at least
4 days of wash-out. The nests were assessed according to the 5-point scale from 1
to 5 as follows54: 1= paper towels not noticeably touched, 2= paper towels scat-
tered throughout the cage, 3= paper towels with little damage in one corner of the
cage, 4= partially shredded but often no identiﬁable nest, 5=mostly shredded into
small pieces and arranged into a circular nest. In all these experiments, all nests
were assessed by two raters blind to the treatments to avoid any possible biases in
scoring the nest completeness.
Feeding behavior assays. During feeding behavior experiments, mice were
individually housed in home cages. All animals were mildly food restricted by
removing chow food during the ﬁnal 8 h before light off (19:00). All tests were
performed using a counter-balanced within-subjects design. Mice received i.p.
injections of either vehicle or CNO (3mg/kg) at 19:00, 15 min before access to ~5 g
of fresh standard chow. Food intake was manually calculated in the home cage by
brieﬂy removing the food from the hopper and obtaining its weight during the dark
period. Food intake was measured at 2 h and 24 h after injection. Subsequent
Fig. 8 Chemogenetic inhibition of NAc D2R neurons increases wakefulness, while activation induces NREM sleep in D2R-Cre mice. a Drawings of
superimposed AAV-DIO-hM4Di injection sites in the NAc of D2R-Cre mice (n= 6, indicated with different colors). b Representative image of hM4Di-
mCherry expression in the NAc. Scale bar: 500 μm. c CNO applied to the bath reduced ﬁring rate in response to 250 pA current injection in an hM4Di-
expressing D2R neuron of brain slice. d Typical examples of compressed spectral array EEG, EMG, and hypnograms over 6 h following administration of
vehicle or CNO in a D2R-Cre mouse with bilateral hM4Di receptor expression in the NAc. e Time course of wakefulness, NREM sleep, and REM sleep
following injection of vehicle or CNO in mice expressing hM4Di receptor in NAc D2R neurons (n= 6, repeated-measures ANOVA; F1, 10= 16.8 (wake), 15.9
(NREM), 14.6 (REM); P= 0.002 (wake), 0.003 (NREM), 0.003 (REM)). f Total time spent in each stage for 2 h after vehicle or CNO injection (n= 6,
paired t test; P= 0.009 (wake), P= 0.01 (NREM), P= 0.012 (REM)). g Drawings of superimposed AAV-DIO-hM3Dq injection sites in the NAc of D2R-Cre
mice (n= 5). h Representative image of hM3Dq-mCherry expression in the NAc. Scale bar: 500 μm. i CNO applied to the bath increased ﬁring rate in
response to 180 pA current injection in an hM3Dq-expressing D2R neuron of brain slice. j Typical examples of compressed spectral array EEG, EMG, and
hypnograms over 6 h following administration of vehicle or CNO in a D2R-Cre mouse with bilateral hM3Dq receptor expression in the NAc. k Time course
of wakefulness, NREM sleep, and REM sleep after administration of vehicle or CNO to mice expressing hM3Dq in NAc D2R neurons (n= 5, repeated-
measures ANOVA; F1,8= 17.8 (wake), 16.9 (NREM), 7.6 (REM); P= 0.003 (wake), 0.003 (NREM), 0.025 (REM)). l Total time spent in each stage for 2 h
after vehicle or CNO injection (n= 5, paired t test; P= 0.003 (wake), P= 0.002 (NREM), P= 0.1 (REM)). *P < 0.05, **P < 0.01
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injections were separated by at least 24 h. Food restriction continued during wash-
out days.
Locomotor activity recordings. Locomotor activity for hM3Dq experiments in
D1R-Cre mice was assessed according to previous studies55. Brieﬂy, movement of an
individual mouse in a recording cage (28 cm × 16.5 cm × 13 cm) was detected with
an overhead infrared sensor (Biotex, Kyoto, Japan). Each mouse was habituated to
the recording cage for 24 h and recorded for the following 3 days. Mice were
injected with vehicle or CNO (1mg/kg or 3mg/kg) at 09:00 or at 21:00 .
In vitro electrophysiology. At 3 to 4 weeks after AAV-ChR2 injections, D1R-Cre
mice or D1R-Cre::GAD67-GFP mice were anesthetized and perfused transcardially
with ice-cold modiﬁed aCSF saturated with 95% O2 and 5% CO2 and containing
(in mM): 215 sucrose, 26 NaHCO3, 10 glucose, 3 MgSO4, 2.5 KCl, 1.25 NaH2PO4,
0.6 mM Na-pyruvate, 0.4 ascorbic acid, and 0.1 CaCl2. Brains were then rapidly
removed, and acute coronal slices (300 μm) containing the NAc, lateral hypotha-
lamus, or midbrain were cut on a vibratome (VT1200, Leica, Germany) in ice-cold
modiﬁed aCSF. Next, slices were transferred to a holding chamber containing
normal recording aCSF (in mM): 125 NaCl, 26 NaHCO3, 25 glucose, 2.5 KCl, 2
CaCl2, 1.25 NaH2PO4 and 1.0 MgSO4, and allowed to recover for 30 min at 32 °C.
Then, slices were maintained at room temperature (RT) for 30 min before
recording.
During recording, slices were submerged in a recording chamber superfused
with aCSF (2 mL/min) at 30–32 °C. Slices were visualized using a ﬁxed-stage
upright microscope (BX51W1, Olympus, Japan) equipped with a 40× water
immersion objective and an infrared-sensitive CCD camera. Expression of ChR2
was conﬁrmed by visualization of mCherry ﬂuorescence in D1R-expressing
neurons and axon terminals. In D1R-Cre::GAD67-GFP mice, GAD67-GFP
neurons were identiﬁed based on their GFP expression. Recordings were performed
in regions with bright mCherry ﬂuorescence. Patch pipettes were fabricated from
thick-walled borosilicate glass capillaries (1.5 mm outer diameter, 0.86 mm internal
diameter, Vital Sense; Scientiﬁc Instruments Co., Ltd, China) using a 2-step vertical
puller (Narishige, PC-10) and had resistances between 4 and 6MΩ. Recording
pipettes were ﬁlled with an internal solution containing (in mM): 105 potassium
gluconate, 30 KCl, 10 phosphocreatine, 4 ATP-Mg, 0.3 EGTA, 0.3 GTP-Na, and 10
HEPES (pH 7.3, 285–300 mOsm). In some experiments, 0.1% biocytin (vol/vol,
Sigma) was included in the internal solution. Recordings were conducted in the
whole-cell or cell-attached conﬁguration using a Multiclamp 700B ampliﬁer (Axon
Instruments). Signals were ﬁltered at 4 kHz and digitized at 10 kHz with a DigiData
1440A (Axon Instruments). Data were acquired and analyzed with
pClamp10.3 software (Axon Instruments).
Responses were evoked by 5 ms light ﬂashes (473 nm, 1–100 Hz) delivered from
a microscope-mounted blue LED (Lumen Dynamics, Canada) through the
objective lens directed onto the slice. The power of the LED light was 3–5 mW. In
the voltage-clamp mode, cells were held at −70 mV. When needed, 25 μM d-
(−)-2-amino-5-phosphonopentanoic acid (d-APV), 5 μM 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX), and 100 μM picrotoxin (PTX) were added to
block NMDA, AMPA, and GABAA receptors, respectively. Series resistance (Rs)
compensation was not used. Therefore, cells with Rs changes over 20% were
discarded.
Single-cell RT-PCR. At the end of the recording, the cytosolic content was aspi-
rated into the patch pipette, and expelled into a 200 μL PCR tube (Axygen, USA) as
described previously56. The single-cell RT-PCR protocol was designed to detect the
presence of mRNAs coding for Vgat. Reverse transcription and the ﬁrst round of
PCR ampliﬁcation were performed with gene-speciﬁc multiplex primer using the
SuperScript III One-Step RT-PCR kit (12574018, ThermoFisher, USA). The ﬁrst
reaction was performed as follows: 30 min at 55 °C, 2 min at 94 °C; 35 cycles of 15 s
at 94 °C, 30 s at 55 °C, and 50 s at 68 °C; and 5 min at 68 °C. A second PCR was
then conducted with nested primers. The ﬁrst PCR product (1–2 μL) was used as
template for a second PCR. In this second round, the reaction was performed as
follows: 2 min at 94 °C; 35 cycles of 15 s at 94 °C, 30 s at 55 °C, and 30 s at 68 °C;
and 5 min at 68 °C. The ﬁnal PCR products were visualized by electrophoresis in
agarose gels (2.0%) with SafeGel. The expected size of each ﬁnal PCR product is
VGAT 250 bp. The speciﬁc primers for Vgat gene were custom designed and
synthesized (Sangon, Shanghai) based on a previous reference57. Sense, 5′ATT-
CAGGGCATGTTCGTGCT3′; antisense, 5′ ATGTGTGTCCAGTTCATCAT3′;
nested, 5′TGATCTGGGCCACATTGACC3′.
Immunohistochemistry. After whole-cell recording, slices containing biocytin-
loaded cells were ﬁxed in 4% paraformaldehyde (PFA), nonspeciﬁc binding was
blocked with 5% donkey serum in phosphate-buffered saline (PBS). Then, slices
were incubated overnight at 4 °C in PBS containing 0.3% Triton-X (PBST), primary
antibodies, and streptavidin conjugated to Alexa 405 or Alexa 488 (1:1000; Invi-
trogen Molecular Probes, USA). Primary antibody was raised against TH (1:3000;
rabbit host; Millipore, USA). The following day, slices were washed 3 times in PBS
and incubated in PBST containing secondary antibodies for 12 h at 4 °C. Secondary
antibody was donkey anti-rabbit 488 or 647 (1:500, Jackson ImmunoResearch).
Finally, slices were washed in PBS and mounted on glass slides using Fluoromount-
GTM (Southern Biotech, 0100–01).
For double immunostaining of c-Fos and mCherry, after optical stimulation or
CNO administration, mice were deeply anesthetized by chloral hydrate (400 mg/
kg) and then perfused intracardially with 20 mL PBS followed by 40 mL 4% PFA.
Brains were removed, postﬁxed for 6 h in 4% PFA, and then incubated in 20%
sucrose phosphate buffer (PB) at 4 °C until they sank. Coronal sections (30 μm)
were cut on a freezing microtome (CM1950, Leica, Germany) in 4 series. The
ﬂoating sections were washed in PBS and incubated with a rabbit polyclonal
antibody against c-Fos (1:10000, pc-38, Calbiochem) in PBST for 48 h at 4 °C on an
agitator. After washing, sections were incubated with a biotinylated goat anti-rabbit
IgG antibody (1:1000, BA-1000, Vector Laboratories) followed by incubation in an
avidin-biotin peroxidase complex (ABC) solution (1:1000, PK-6100, Vector
Laboratories) for 1 h. After rinsing, the sections were immersed in a 3,3-
diaminobenzidine-4 HCl (DAB) and nickel solution (SK-4100, Vector
Laboratories) for 5–10 min at RT, in which Fos-immunoreactive neurons were
identiﬁed by the presence of black reaction product. The following day, the c-Fos
immunostained sections were incubated in a rabbit polyclonal antibody against
DsRed (mCherry tag, 1:5000, 632496, Clontech) overnight at 4 °C. Ampliﬁcation
steps were similar to those described above, except that the last step was performed
in a DAB solution without nickel ammonium sulfate. Finally, the sections were
mounted on glass slides, dried, dehydrated, and coverslipped.
For circuit mapping, mouse brains were ﬁxed and prepared as described above.
Coronal cryostat sections (30 μm) were incubated in 3% normal donkey serum
PBST for 2 h and then in primary antibodies in PBST overnight at RT. The
following primary antibodies were used: rabbit anti-SP (1:400, ABN1369,
Millipore), goat anti-Orexin-A (1:500, sc-8070, Santa Cruz Biotechnology), mouse
anti-TH (1:1000, T2928, Sigma), goat anti-PV (1:3000, PVG213, Swant), and
mouse anti-lhx6 (1:500, sc-271433, Santa Cruz Biotechnology). Next, sections were
rinsed 3 times in PBS and incubated for 2 h at RT with the following secondary
antibodies: donkey anti-rabbit 488 (for SP, 1:500, 711-545-152, Jackson
ImmunoResearch), donkey anti-mouse 488 (for TH and lhx6, 1:1000, A-21202,
Invitrogen), donkey anti-goat 647 (for Orexin-A, 1:1000, A21447, Invitrogen), and
donkey anti-goat 488 (for PV, 1:500, 711-545-147, Jackson ImmunoResearch).
Some sections were also incubated in 4,6-diamidino-2-phenylindole (DAPI, 1:3000,
D1306, Invitrogen) for 7 min at RT. Finally, sections were washed 2 times in PBS,
mounted on slides, and coverslipped.
Nonconfocal images were captured by a ﬂuorescence microscope (IX71,
Olympus). High-resolution ﬂuorescence images were collected on a confocal
microscope (FV-1000, Olympus). Digital images were processed using FV-1000
Viewer 2.0 and Adobe Photoshop CS3 software to minimally adjust brightness and
contrast. All digital images were processed in the same way between experimental
conditions to avoid artiﬁcial manipulation between different data sets.
Electron microscopy. Under deep anesthesia, D1R-Cre mice injected with AAV-
ChR2-mCherry in the NAc were brieﬂy rinsed transcardially with 6–8 mL saline
and then perfused with 100 mL ice-cold ﬁxative which contains 4% PFA, 15%
saturated picric acid in 0.1 M PB, and 0.5% glutaraldehyde. Immediately after
perfusion–ﬁxation, the brain was removed from the skulls and postﬁxed in 4% PFA
for 2 h at 4 °C. The brain containing the midbrain was cut into coronal sections (40
μm) with a vibratome (VT1000S, Leica, Germany) and collected in 0.05M PB for
subsequent mCherry and TH double staining. The sections were placed in 0.05M
PB (pH 7.4) containing 10% (v/v) glycerol and 25% (w/v) sucrose for 1 h and then
freeze–thawed with liquid nitrogen to enhance penetration of antibody. The sec-
tions were then incubated in rabbit polyclonal antibody against DsRed (1:5000) in
0.05 M PB at 4 °C for 30–36 h. At RT, the sections were then incubated with goat
anti-rabbit biotinylated IgG (1:1000) for 3 h, followed by incubation in ABC
complex for 3 h. After mCherry immunoreactivity was visualized with DAB fol-
lowing the same procedure as we used for light microscopy, the brain sections were
incubated in rabbit anti-TH antibody (1:1000, Millipore) containing 5% normal
donkey serum at 4 °C for 30–36 h. Then, the sections were incubated in goat anti-
rabbit biotinylated IgG (1:1000) followed by ABC solution at RT for 3 h. A
chromogen of the VIP substrate kit (SK-4600, Vector Laboratories) was used to
visualize TH immunoreactivity. The double-labeled sections were osmicated with
OsO4 (2%), dehydrated in a graded series of ethanol, and embedded ﬂat in Epon 12
(Ted Pella, USA) using embedding capsules (TAAB, UK). The sections embedded
were observed under a light microscope, and the area containing labeled axons and
TH cell bodies in the midbrain was sampled. Ultrathin sections were obtained
using an ultramicrotome at 70 nm, stained with uranyl acetate and lead citrate, and
then examined in a CM-120 transmission electron microscope (Philips,
Netherlands).
Statistical analysis. Data are presented as mean ± s.e.m. Sample sizes were chosen
based on previous studies12,58. No method of randomization or blinding was used
in the experiments except for nest-building test. Two-way repeated-measures
analysis of variance (ANOVA) was used to perform group comparisons with
multiple measurements. Paired and unpaired t tests were used for single value
comparisons. One-way ANOVA was used to compare more than two groups,
followed by post hoc Turkey test analysis for multiple comparisons. Two sets of
frequencies were analyzed by chi-square test. Nest-building behavior was tested by
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Wilcoxon matched-pairs signed rank tests. A two-tailed P value of <0.05 was
considered statistically signiﬁcant. Statistical analysis was performed using SPSS
16.0 software.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author on request.
Code availability. Data analyses were conducted in Matlab using scripts available
from the corresponding author upon reasonable request.
Received: 6 August 2017 Accepted: 20 March 2018
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